This inventor holds 4 USPTO granted patents and 2 EPO patents. Top assignees: Astellas Pharma Gmbh, Kotobuki Pharmaceutical Co Ltd, Kotobuki Pharmaceuticals Co., Ltd.. Active years: 2018-2021.
Company Filing History:
4 out of 424 
3 out of 27 
1 out of 2 Years Active: 2018-2021
Title: Junichi Kazami: Innovator in Pharmaceutical Chemistry
Introduction
Junichi Kazami is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds aimed at treating nocturia. With a total of 4 patents to his name, Kazami's work reflects a commitment to addressing critical health issues through innovative solutions.
Latest Patents
Kazami's latest patents focus on pyridine derivatives that serve as pharmaceutical compositions for treating nocturia. The primary problem addressed by this invention is the need for compounds that can effectively inhibit the nocturnal activity of placental leucine aminopeptidase (P-LAP). By maintaining or increasing endogenous arginine vasopressin (AVP) levels, these compounds enhance the antidiuretic effect, thereby reducing the frequency of nocturnal voids. The inventors have identified that (2R)-3-amino-2-{[4-(substituted pyridine)-2-yl]methyl}-2-hydroxy-propanoic acid derivatives exhibit excellent P-LAP inhibitory activity. Through evaluations conducted on water-loaded rats, it has been demonstrated that these compounds can increase endogenous AVP levels and consequently reduce urine production. This innovative approach positions Kazami's work as a promising avenue for treating nocturia.
Career Highlights
Throughout his career, Junichi Kazami has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Astellas Pharma GmbH and Kotobuki Pharmaceutical Co. Ltd. His experience in these organizations has contributed to his expertise in developing effective pharmaceutical solutions.
Collaborations
Kazami has collaborated with esteemed colleagues, including Kenichi Kawaguchi and Akihiro Ishihata. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to the development of impactful pharmaceutical products.
Conclusion
Junichi Kazami's contributions to pharmaceutical chemistry, particularly in the area of nocturia treatment, highlight his role as an influential inventor. His innovative work and collaborations continue to pave the way for advancements in healthcare solutions.